Kura Oncology, Inc. (KURA) Social Stream
KURA ONCOLOGY INC (KURA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KURA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 5 | $53 | $41 | $47.25 | $14.87 | 217.75% |
| 2021-11-24 | 5 | $50 | $40 | $44 | $14.87 | 195.9% |
| 2021-12-14 | 5 | $50 | $32 | $40.75 | $14.87 | 174.04% |
| 2022-01-03 | 6 | $56 | $32 | $42.25 | $14.87 | 184.13% |
| 2022-02-25 | 6 | $56 | $32 | $40.8 | $14.87 | 174.38% |
| 2022-05-05 | 6 | $56 | $28 | $38.2 | $14.87 | 156.89% |
| 2022-07-12 | 7 | $56 | $28 | $36.833 | $14.87 | 147.7% |
| 2022-08-04 | 6 | $40 | $28 | $33.2 | $14.87 | 123.27% |
| 2022-11-03 | 7 | $40 | $28 | $33.2 | $14.87 | 123.27% |
| 2022-12-12 | 7 | $40 | $28 | $32.666 | $14.87 | 119.68% |
| 2023-01-24 | 7 | $40 | $28 | $32.5 | $14.87 | 118.56% |
| 2023-01-31 | 8 | $40 | $25 | $31.428 | $14.87 | 111.35% |
| 2023-02-09 | 7 | $40 | $25 | $31.857 | $14.87 | 114.24% |
| 2023-02-24 | 8 | $40 | $25 | $31.857 | $14.87 | 114.24% |
| 2023-04-19 | 9 | $40 | $22 | $30.625 | $14.87 | 105.95% |
| 2023-05-11 | 9 | $40 | $22 | $30.5 | $14.87 | 105.11% |
| 2023-05-17 | 10 | $40 | $22 | $30.555 | $14.87 | 105.48% |
| 2023-06-12 | 10 | $40 | $22 | $30.666 | $14.87 | 106.23% |
| 2023-07-11 | 10 | $40 | $22 | $30.444 | $14.87 | 104.73% |
| 2023-08-04 | 10 | $40 | $22 | $30.333 | $14.87 | 103.99% |
| 2023-08-11 | 11 | $40 | $22 | $30.1 | $14.87 | 102.42% |
| 2023-10-18 | 12 | $40 | $22 | $30.1 | $14.87 | 102.42% |
| 2023-11-03 | 13 | $37 | $22 | $29.8 | $14.87 | 100.4% |
| 2023-12-22 | 14 | $37 | $22 | $29.454 | $14.87 | 98.08% |
The Trend in the Analyst Price Target
KURA's average price target has moved down $14.22 over the prior 34 months.
Over the past 47 weeks, KURA's average upside potential has been 173.27%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-24 | 7 | 40 | 28 | 32.500 | 14.09 | 130.66% |
| 2023-06-12 | 10 | 40 | 22 | 30.666 | 12.88 | 138.09% |
| 2023-08-11 | 11 | 40 | 22 | 30.100 | 11.86 | 153.79% |
| 2023-09-29 | 12 | 40 | 22 | 30.100 | 9.12 | 230.04% |
| 2023-11-03 | 13 | 37 | 22 | 29.818 | 9.01 | 230.94% |
KURA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.14 | 13 | 0 | 1 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
KURA's average broker recommendation rating worsened by 0.14 over the prior 23 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KURA as an investment opportunity.
- KURA has a greater upside potential (average analyst target price relative to current price) than 2394.92% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, KURA ONCOLOGY INC's number of analysts covering the stock is greater than 2416.82% of them.
- KURA has a greater average analyst price target than 2271.77% of stocks in the small market cap category.
- In terms of how KURA ONCOLOGY INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -885.71% of that group.
In the Pharmaceutical Products industry, GALT, ORIC, and ANNX are the three stocks most similar to KURA ONCOLOGY INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is KURA a Buy, Hold or Sell? See the POWR Ratings now!